Wooree Bio Co.,Ltd

KOSDAQ:A082850 Stock Report

Market Cap: ₩149.9b

Wooree BioLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Wooree BioLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Semiconductor earnings growth38.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%

Oct 23
Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%

Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%

Sep 07
Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%

Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns

Aug 30
Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns

Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?

Aug 10
Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?

Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up

Jul 19
Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up

Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising

May 25
Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising

These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well

May 03
These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well

Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too

Apr 26
Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too

Should You Invest In Wooree BioLtd (KOSDAQ:082850)?

Feb 28
Should You Invest In Wooree BioLtd (KOSDAQ:082850)?

Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly

Feb 01
Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly

Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Jan 12
Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain

Dec 21
Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain

Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative

Nov 29
Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Wooree BioLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A082850 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20241,303,98215,86625,73944,173N/A
3/31/20241,288,39116,26144,46854,973N/A
12/31/20231,263,94415,58115,94926,515N/A
9/30/20231,210,01812,899-3,7877,103N/A
6/30/20231,168,69010,40410,47220,860N/A
3/31/20231,272,91115,98713,92124,851N/A
12/31/20221,355,05621,82229,92843,353N/A
9/30/20221,483,23131,10742,63258,779N/A
6/30/20221,528,81932,78551,62864,832N/A
3/31/20221,527,45230,71123,08138,679N/A
12/31/20211,543,31233,15637,44350,208N/A
9/30/20211,577,02123,35120,24731,361N/A
6/30/20211,668,10823,94934,86248,264N/A
3/31/20211,621,46723,28861,41776,607N/A
12/31/20201,623,38316,84151,32869,427N/A
9/30/20201,600,03121,43870,13387,897N/A
6/30/20201,580,79617,50312,24431,127N/A
3/31/20201,682,9153,72954,39474,655N/A
12/31/20191,672,6484,53242,00565,803N/A
9/30/20191,635,873-2,0609,44535,163N/A
6/30/20191,539,163-10,32138,81066,582N/A
3/31/20191,358,099-18,184-15,43315,941N/A
12/31/20181,279,627-32,888-18,44110,824N/A
9/30/20181,343,043-46,169-16,43118,908N/A
6/30/20181,258,947-43,52521,01063,020N/A
3/31/20181,359,443-33,208N/A22,586N/A
12/31/20171,474,632-28,041N/A27,730N/A
9/30/20171,391,349-4,458N/A22,482N/A
6/30/20171,497,664-11,950N/A-12,865N/A
3/31/20171,489,526-21,295N/A20,483N/A
12/31/20161,533,519-23,261N/A-1,948N/A
9/30/20161,290,944-57,516N/A-1,215N/A
6/30/20161,327,188-55,845N/A16,492N/A
3/31/20161,803,498-48,526N/A-3,492N/A
12/31/20151,764,595-42,887N/A-11,529N/A
9/30/20152,055,453-19,841N/A53,573N/A
6/30/20151,921,805-18,299N/A56,328N/A
3/31/20151,394,152-23,046N/A64,814N/A
12/31/20141,305,507-29,308N/A54,312N/A
9/30/20141,055,754-29,361N/A-10,241N/A
6/30/20141,099,397-31,564N/A-37,988N/A
3/31/20141,055,242-19,463N/A-27,255N/A
12/31/20131,039,767-10,886N/A80,751N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A082850's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A082850's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A082850's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A082850's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A082850's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A082850's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y